Company profile · Frankfurt, Germany

ICON Germany

Clinical Research Operations, Monitoring, and Trial Delivery Services · Global CRO network with Germany execution node

GermanyCROFrankfurt

ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.

Lead
Barry Balfe (verified ↗)
Address
Frankfurt, Germany (source ↗)
Compliance
GCP-aligned full-service CRO platform
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global CRO network with Germany execution node
Capabilities
Clinical Monitoring · Trial Management · Clinical Data Delivery
Founded
1990
Headcount
10000+
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Barry Balfe

Chief Executive Officer

Check official leadership source
Full addressFrankfurt, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official ICON Germany careers page listing Frankfurt as an active Germany location.

Open source
Operating profile

Global CRO network with Germany execution node

Frankfurt, Germany. Clinical Research Operations, Monitoring, and Trial Delivery Services. Review completed on 14 Mar 2026.

2026 technical specializationClinical Research Operations, Monitoring, and Trial Delivery Services
Core capabilities
Clinical MonitoringTrial ManagementClinical Data DeliverySponsor Support
Governance

German, EU, and global clinical-trial oversight

GCP-aligned full-service CRO platform, Clinical and data-governance controls

Editorial note

Clinical Research Operations, Monitoring, and Trial Delivery Services

ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.

Editorial note

ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Clinical Monitoring
Trial Management
Clinical Data Delivery
Sponsor Support
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceICON official September 2025 CEO transition release.Source origin: investor.iconplc.comOpen source
Supporting evidenceICON official Germany careers page referencing Frankfurt and Germany operations.Source origin: careers.iconplc.comOpen source
Physical-site evidenceOfficial ICON Germany careers page listing Frankfurt as an active Germany location.Source origin: careers.iconplc.comOpen source
Infrastructure

Declared infrastructure

Monitoring workflows
Clinical data systems
Project-delivery infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is ICON Germany located?
ICON Germany operates from Frankfurt, Germany, Frankfurt, Germany.
Who runs ICON Germany?
ICON Germany is led by Barry Balfe, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does ICON Germany hold?
ICON Germany is documented under GCP-aligned full-service CRO platform.
What does ICON Germany do?
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node. Core capabilities: Clinical Monitoring, Trial Management, Clinical Data Delivery, Sponsor Support.
Editorial context

Related technical briefs

Briefs that name Frankfurt as a covered market or city.